Isoniazid Oral: Dosing, Duration, and Precautions
Isoniazid guidance for tuberculosis and latent tuberculosis protocols, with pyridoxine support and hepatotoxicity precautions.
Also searched as
Source reviewed
source date listed on the source page
Guide category
Oral drugs
Safety boundary
Prescription medicine information for clinician-guided use.
Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.
Therapeutic action
Antituberculosis antibacterial.
Indications
- Tuberculosis, in combination therapy according to protocol.
- Latent tuberculosis in combination regimens according to protocol.
Forms and strengths
- 100 mg and 300 mg tablets.
Dose
According to protocol.
Duration
- Tuberculosis as monotherapy: according to protocol.
- Latent tuberculosis in combination with daily rifampicin or weekly rifapentine: 3 months.
- Latent tuberculosis in combination with daily rifapentine: 1 month.
Contra-indications, adverse effects, precautions
- Do not administer to patients with severe hepatic impairment.
- May cause peripheral neuropathy, especially in malnourished, alcoholic, diabetic, HIV-infected, pregnant and breast-feeding women, and patients with renal impairment.
- May cause hepatotoxicity, hypersensitivity reactions, psychotic reactions, seizures, and depression.
- Monitor liver function in patients with known hepatic disease.
- If signs of hepatotoxicity develop, discontinue isoniazid until symptoms resolve.
- Administer with caution and closely monitor patients taking phenytoin, carbamazepine, benzodiazepines, or warfarin.
- Administer pyridoxine (vitamin B6) in patients at risk of peripheral neuropathy: child 5 to 10 mg once daily; adult 10 mg once daily.
- Pregnancy: no contra-indication. Administer pyridoxine to the mother.
- Breast-feeding: no contra-indication. Administer pyridoxine to the mother and infant.
Source
MSF Essential drugs practical guidelines (January 2026)
This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.
Rate this guide
Be the first to rate this guide.
